Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 100 #1
CompanyRegulus Therapeutics Inc.
Market Cap751.95MEPS (ttm)-0.67
P/E-EPS this Y76.90%
Forward P/E-EPS next Y27.70%
PEG-EPS past 5Y0.00%
P/S54.10EPS next 5Y-
P/B9.17EPS Q/Q-40.00%
Dividend-Sales Q/Q-85.40%
Insider Own0.20%Inst Own33.10%
Insider Trans-70.86%Inst Trans-0.02%
Short Float11.86%EarningsNov 11/a
Analyst Recom1.70Target Price16.40
Avg Volume596.41K52W Range5.40 - 15.74
23-Oct-14 03:39PM3 Momentum Stocks to Watch in Biotechnology for Continued Upside at TheStreet
23-Oct-14 10:49AMCan The Uptrend Continue for Regulus Therapeutics (RGLS)? Zacks
23-Oct-14 06:30AMStrength Seen in Regulus (RGLS): Stock Soars 103.1% Zacks
22-Oct-14 04:28PMAs earnings season heats up, stocks close on the lows Yahoo Finance Blogs
22-Oct-14 01:50PMRegulus surges on early hepatitis C drug data AP
22-Oct-14 11:52AMRegulus Gets Seat at Hep C Table With Today's Impressive Drug Results at TheStreet
22-Oct-14 10:39AMRegulus Therapeutics Soars 90% On Hepatitis C Treatment News Benzinga
22-Oct-14 08:48AMREGULUS THERAPEUTICS INC. Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
22-Oct-14 08:30AMRegulus Therapeutics Inc. RG-101 Human Proof of Concept Call scheduled for 8:30 am ET today CCBN
22-Oct-14 07:30AMA Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Tr PR Newswire
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. The company uses its microRNA product platform to develop anti-miRs, which is chemically modified and single-stranded oligonucleotide. Its clinical candidate products include RG-101, which is a GalNAc-conjugated anti-miR that targets microRNA-122 for the treatment of patients with chronic hepatitis C virus infection. The company has strategic collaboration with Biogen Idec MA Inc. for the evaluation of the use of microRNA signatures as a biomarker for human patients with multiple sclerosis; AstraZeneca AB to discover and develop microRNA therapeutics for cardiovascular diseases, metabolic diseases, and oncology; and GlaxoSmithKline plc to discover and develop microRNA therapeutics for immuno-inflammatory diseases. It also has strategic collaboration with Sanofi for the discovery and development of microRNA therapeutics comprising miR-21 pre-clinical fibrosis program for the treatment of alport syndrome and preclinical program for oncology indications; and preclinical programs targeting miR-221/222 for oncology indications. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ISIS PHARMACEUTICALS INCDirectorOct 24Sale15.191,85028,1096,795,716Oct 24 09:29 PM
ISIS PHARMACEUTICALS INCDirectorOct 23Sale14.241,70024,2026,797,566Oct 24 09:29 PM
Gibson Neil WChief Scientific OfficerOct 22Option Exercise1.743,3005,74283,300Oct 24 04:16 PM
ISIS PHARMACEUTICALS INCDirectorOct 22Sale14.00109,5341,533,1256,799,266Oct 24 09:29 PM
Gibson Neil WChief Scientific OfficerOct 22Sale14.443,30047,64480,000Oct 24 04:16 PM
CompanyAvanir Pharmaceuticals, Inc.
IndustryDrugs - Generic
Market Cap2.28BEPS (ttm)-0.47
P/E-EPS this Y-17.80%
Forward P/E-EPS next Y-31.00%
PEG-EPS past 5Y-14.40%
P/S21.96EPS next 5Y-
P/B29.63EPS Q/Q0.00%
Dividend-Sales Q/Q44.40%
Insider Own0.60%Inst Own64.80%
Insider Trans-6.62%Inst Trans-1.58%
Short Float8.13%EarningsAug 05/a
Analyst Recom1.80Target Price17.80
Avg Volume5.49M52W Range2.62 - 13.09
22-Oct-14 03:10PM6 stocks to watch at MarketWatch
17-Oct-14 07:05AMBiotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents at TheStreet
15-Oct-14 05:04PMConcert Pharmaceuticals Announces Positive CTP-354 Data Zacks
14-Oct-14 05:05PMAvanir (AVNR) Presents Detailed Phase II Data on AVP-923 Zacks
13-Oct-14 04:26PMAvanir Pharmaceuticals Announces Presentation of AVP-923 Phase II Results in Agitation in Patients with Alzheimer's Disease at the American Neurological Association Meeting PR Newswire
08-Oct-14 04:15PMAvanir Pharmaceuticals to Host Investor Briefing on October 15, 2014 PR Newswire
08-Oct-14 08:30AMAvanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease PR Newswire
01-Oct-14 06:49PMLightning Round: Manitowoc, Harman Int'l & more at CNBC
29-Sep-14 09:15AMAvanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire
25-Sep-14 03:09PMAVANIR PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online
Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA, a dual N-methyl-D-aspartate receptor antagonist and sigma-1 agonist for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. The company's clinical development stage products comprise AVP-923, which has completed Phase II clinical trials for the treatment of central neuropathic pain in patients with multiple sclerosis; is in Phase II clinical trials for the treatment of agitation in patients with Alzheimer's disease; and is in Phase II clinical trials for the treatment of levodopa-induced-dyskinesia in Parkinson's disease, as well as completed Phase III trials for the treatment of patients with diabetic peripheral neuropathic pain. It is also developing AVP-786, a Phase I clinical trial novel investigational drug product for the treatment of neurologic and psychiatric disorders; and AVP-825, an investigational drug-device combination product, which is in Phase III clinical trials, to treat acute migraine. The company has a license agreement with Concert Pharmaceuticals, Inc. to develop and commercialize deuterium-modified dextromethorphan for the potential treatment of neurologic and psychiatric disorders, as well as rights to other deuterium-modified dextromethorphan compounds; and a license agreement with OptiNose AS for the development and commercialization of a novel breath powered intranasal delivery system to treat acute migraine. Avanir Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Siffert Joao MDSVP, R&DOct 24Sale11.808,42699,427222,554Oct 24 08:48 PM
OCAMPO CHRISTINEVice President, FinanceOct 24Sale11.812,08024,56577,791Oct 24 08:22 PM
OCAMPO CHRISTINEVice President, FinanceSep 15Sale9.4555,000519,75079,871Sep 17 08:44 PM
PALEKAR ROHANSVP & Chief Commercial OfficerSep 15Sale11.5025,000287,500266,750Sep 17 08:28 PM
OCAMPO CHRISTINEVice President, FinanceAug 26Sale6.102,11012,87179,871Aug 28 09:03 PM
TickerCRM [NYSE, S&P 500]
CompanySalesforce.com, Inc
IndustryApplication Software
Market Cap36.87BEPS (ttm)-0.66
P/E-EPS this Y18.80%
Forward P/E83.90EPS next Y37.86%
PEG-EPS past 5Y-44.70%
P/S7.74EPS next 5Y27.80%
P/B11.13EPS Q/Q-183.30%
Dividend-Sales Q/Q37.80%
Insider Own0.30%Inst Own97.00%
Insider Trans-46.10%Inst Trans0.05%
Short Float6.21%EarningsNov 17/a
Analyst Recom1.80Target Price69.23
Avg Volume4.90M52W Range48.18 - 67.00
24-Oct-14 02:32PMAre we in a tech bubble? Silicon Valley says yes and no at Fortune
24-Oct-14 10:16AMMicrosoft's earnings relief: Pro CNBC
23-Oct-14 11:35AMOn Salesforce's Wave Platform And Why Semantic Debates About Analytics Are Irrelevant at Forbes
23-Oct-14 11:19AMCloud computing still castles in the air for some tech investors at Financial Times
22-Oct-14 12:13PMTelevision prepares a bigger menu at Financial Times
22-Oct-14 09:49AMIllumio benefits from funding boom in cyber security at Financial Times
21-Oct-14 08:13PMBig Data Opportunity: Predictive Sales Software Turns Browsers Into Buyers at Forbes
21-Oct-14 12:00PMCotap Launches External Messaging and Salesforce.com Integration Marketwired
21-Oct-14 07:15AMAdvice to tech companies on diversity: Own the story at Fortune
21-Oct-14 06:01AMSALESFORCE COM INC Files SEC form 8-K, Other Events EDGAR Online
salesforce.com, inc. provides enterprise cloud computing solutions to various businesses and industries worldwide. The company offers social and mobile cloud apps and platform services, including Sales Cloud for sales force automation, which enables companies to grow their sales pipelines, close deals, improve sales productivity, and gain business insights; Service Cloud that enables companies to connect with their customers and address their service and support needs; Marketing Cloud, which enables companies to bring in data from any source and deliver personalized interactions to any customer across any channel through email, mobile, social, Web, marketing automation, and data analytics from a single platform; and Salesforce1 Platform, a cloud platform for developing customer apps. It also provides professional services, including consulting, deployment, training, implementation, integration, and campaign services to its customers to facilitate the adoption of its social and mobile cloud solutions. salesforce.com, inc. sells and markets its services primarily through its direct sales force, as well as through global consulting firms, systems integrators, and regional partners. The company has a strategic alliance with Koninklijke Philips N.V. to develop and deliver an open cloud-based healthcare platform. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hu GeorgeChief Operating OfficerOct 24Option Exercise16.363,50057,26031,902Oct 24 08:36 PM
Benioff MarcChairman of the Board & CEOOct 24Sale58.9920,0001,179,82439,190,000Oct 24 08:32 PM
Hu GeorgeChief Operating OfficerOct 24Sale58.903,500206,13328,402Oct 24 08:36 PM
Hu GeorgeChief Operating OfficerOct 23Option Exercise16.363,50057,26031,902Oct 24 08:36 PM
Dayon AlexandrePres, Applications & PlatformOct 23Sale56.9041623,6700Oct 23 07:46 PM
CompanyTwitter, Inc.
IndustryInternet Information Providers
Market Cap30.73BEPS (ttm)-2.02
P/E-EPS this Y155.60%
Forward P/E135.00EPS next Y277.55%
PEG-EPS past 5Y0.00%
P/S31.55EPS next 5Y-
P/B9.76EPS Q/Q-166.70%
Dividend-Sales Q/Q124.10%
Insider Own0.90%Inst Own53.60%
Insider Trans-94.51%Inst Trans-5.73%
Short Float4.85%EarningsOct 27/a
Analyst Recom2.50Target Price53.94
Avg Volume26.99M52W Range29.51 - 74.73
25-Oct-14 04:31PMTwitter Acquires Photo-Sharing Website Twitpic's Domain And Photo Archive Business Insider
25-Oct-14 04:12PMTwitpic's last-minute deal with Twitter keeps your old photos safe at Engadget
25-Oct-14 01:08PMHow to pick a college? Data crunchers can help at USA TODAY
25-Oct-14 11:27AMEbola in New York fires up the media at USA TODAY
25-Oct-14 09:00AMLater, Peyton: The new face of sports endorsements at CNBC
25-Oct-14 08:15AMMaking the most of early holiday shopping at USA TODAY
24-Oct-14 05:39PMFCC: Phone companies posted private info online at USA TODAY
24-Oct-14 04:52PMDid the Queen signal a top in Twitter? Talking Numbers
24-Oct-14 04:32PMTwitter open sources an anomaly-detection tool paidContent.org
24-Oct-14 03:24PMTwitter Q3 Might Show Payoff From New Products at Investor's Business Daily
Twitter, Inc. is a global platform for public self-expression and conversation in real time. It provides various products for users, including Twitter that allows users to express themselves and create, distribute, and discover content; Vine, a mobile application available on the iOS, Android, and Windows operating systems that enables users to create and distribute short looping videos; and #Music, a mobile application that helps users discover new music and artists based on Tweets. The company also provides a set of tools, public APIs, and embeddable widgets that developers can use to contribute their content to its platform; distribute Twitter content across their properties; and enhance their Websites and applications with Twitter content. In addition, Twitter, Inc. offers promoted products, including promoted tweets, promoted accounts, and promoted trends that enable its advertisers to promote their brands, products, and services; and provides subscription access to its data feed for data partners. The company was founded in 2006 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baratta LucaVP, Finance and Accounting OffOct 23Option Exercise1.835,2099,532366,549Oct 24 08:21 PM
Baratta LucaVP, Finance and Accounting OffOct 23Sale49.9210,000499,160356,549Oct 24 08:21 PM
Baratta LucaVP, Finance and Accounting OffOct 22Option Exercise1.83417763361,757Oct 24 08:21 PM
Baratta LucaVP, Finance and Accounting OffOct 22Sale51.1041721,309361,340Oct 24 08:21 PM
Roetter AlexanderVP, EngineeringOct 08Option Exercise1.837821,431975,300Oct 10 06:56 PM
CompanySynchronoss Technologies, Inc.
IndustryApplication Software
Market Cap1.93BEPS (ttm)0.87
P/E53.02EPS this Y-15.90%
Forward P/E23.73EPS next Y16.41%
PEG2.60EPS past 5Y9.40%
P/S4.96EPS next 5Y20.36%
P/B3.81EPS Q/Q122.20%
Dividend-Sales Q/Q23.50%
Insider Own2.10%Inst Own84.00%
Insider Trans-0.79%Inst Trans0.40%
Short Float7.32%EarningsOct 28/b
Analyst Recom1.50Target Price49.55
Avg Volume506.57K52W Range25.28 - 47.81
14-Oct-14 04:05PMSynchronoss Technologies, Inc. Announces Date of Third Quarter 2014 Financial Results Business Wire
09-Oct-14 10:15AMInsider Trading Alert - SNCR, SPLK And HNT Traded By Insiders at TheStreet
06-Oct-14 10:15AMInsider Trading Alert - BLUE, NVAX And SNCR Traded By Insiders at TheStreet
30-Sep-14 05:05PMStock Indexes Post Small Losses, But Small Caps Sink Fast at Investor's Business Daily
30-Sep-14 01:20PMRally Loses Steam; Oil Stocks Stumble at Investor's Business Daily
29-Sep-14 01:32PMRebound Efforts Fade For Stocks; Synchronoss Clears Resistance at Investor's Business Daily
10-Sep-14 06:15AMSmarter Smartphone Stocks at Forbes
06-Sep-14 08:01AMMeet 5 IBD 50 Stocks Expanding Into New Markets at Investor's Business Daily
05-Sep-14 06:45PMIBD 50 Showing Little Distress, But Few Big Winners at Investor's Business Daily
05-Sep-14 06:15PMAt Synchronoss, Innovation And Execution Mesh Well at Investor's Business Daily
Synchronoss Technologies, Inc. provides cloud solutions and software-based activation for connected devices worldwide. The company's services include intelligent connectivity management and content synchronization, backup, and sharing services, as well as device and service procurement, provisioning, activation, and support services that enable communications service providers, cable operators/multi-services operators, original equipment manufacturers with embedded connectivity, multi-channel retailers, and other customers to accelerate and monetize their go-to-market strategies for connected devices. Its Activation Services, Synchronoss Personal Cloud, Synchronoss WorkSpace, and Synchronoss Integrated Life platforms provide end-to-end seamless integration between customer-facing channels/applications, communication services or devices, and back-office infrastructure-related systems and processes. The company markets and sells its services through direct sales force and strategic partners. Synchronoss Technologies, Inc. was founded in 2000 and is headquartered in Bridgewater, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOFFMAN CHARLES EDirectorOct 22Option Exercise18.9820,000379,60041,591Oct 24 07:03 PM
Moore DonnieDirectorOct 22Option Exercise27.927,500209,40024,175Oct 24 07:33 PM
HOFFMAN CHARLES EDirectorOct 22Sale46.3520,000927,00021,591Oct 24 07:03 PM
Moore DonnieDirectorOct 22Sale46.347,500347,55016,675Oct 24 07:33 PM
Prague RonaldEVP and General CounselOct 21Option Exercise14.005,00070,00039,428Oct 23 07:44 PM
CompanyBarracuda Networks, Inc.
IndustryCommunication Equipment
Market Cap1.49BEPS (ttm)0.02
P/E1430.00EPS this Y33.30%
Forward P/E91.67EPS next Y20.93%
PEG45.04EPS past 5Y-23.80%
P/S5.84EPS next 5Y31.75%
P/B190.67EPS Q/Q125.00%
Dividend-Sales Q/Q18.90%
Insider Own19.70%Inst Own49.10%
Insider Trans-19.77%Inst Trans0.31%
Short Float4.04%EarningsOct 09/a
Analyst Recom1.90Target Price38.94
Avg Volume208.55K52W Range18.63 - 44.40
24-Oct-14 06:58AMServiceNow, Inc. (NOW) in Focus: Stock Soars 11.1% Zacks
18-Oct-14 01:04PMBARRACUDA NETWORKS INC Financials EDGAR Online Financials
16-Oct-14 05:00AM'Fast Money' Recap: Scared Investors Continue to Avoid the Market at TheStreet
15-Oct-14 08:30AMCloud-Connected Archiving, Easy Capacity Expansion and Federated Search Provided by Barracuda Message Archiver version 4.0 PR Newswire
15-Oct-14 08:19AMCan The Uptrend Continue for Barracuda (CUDA)? Zacks
15-Oct-14 06:58AMWhy Barracuda Networks (CUDA) Could Be Positioned for a Surge? Zacks
14-Oct-14 05:37PMPalo Alto CEO: Rapid customer adoption CNBC
14-Oct-14 05:37PM[video] Palo Alto CEO: Rapid customer adoption at CNBC
14-Oct-14 09:35AM3 Big-Volume Stocks in Breakout Territory at TheStreet
14-Oct-14 08:30AMBarracuda Delivers New Features and Flexibility for Cloud-Connected and Private Environments with Barracuda Backup version 6.0 and the New Barracuda Backup 995 PR Newswire
Barracuda Networks, Inc. designs and delivers security and storage solutions. It offers cloud-connected solutions that help its customers address security threats, enhance network performance, and protect and store their data. The company provides various security solutions, including Barracuda Spam & Virus Firewall, an email security solution; Barracuda Web Filter, a Web security solution to protect users from rapidly evolving Web-based threats, as well as to enhance productivity and optimize bandwidth; next-generation firewall solutions; Barracuda Web Application Firewall, an application security solution for protecting Web servers from data breaches and downtime; Barracuda Load Balancer ADC that optimizes application performance, availability, and security; and Barracuda SSL VPN, which offers remote users with secure access to internal network resources from any Web browser while providing the security needed to protect internal systems from unauthorized access, viruses, and other malware. It also offers storage solutions comprising Barracuda Backup, an end-to-end solution that simplifies the backup process and enables secure offsite replication; Barracuda Message Archiver that reduces archive sizes through eliminating duplicate messages, storing only one instance of each message attachment, and then compressing the stored data; Copy, a cloud-based file storage platform that allows its customers to securely access, share, and sync files of any size from any device; and SignNow, a mobile eSignature application. The company sells its appliances, services, and software products to education, government, financial services, healthcare, professional services, telecommunications, retail, and manufacturing industries through its sales personnel, distribution partners, and value added resellers in approximately 100 countries worldwide. Barracuda Networks, Inc. was founded in 2003 and is headquartered in Campbell, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Perone Michael DChief Marketing Officer & EVPOct 24Sale28.821,12032,2785,385,802Oct 24 06:56 PM
Perone Michael DChief Marketing Officer & EVPOct 24Sale28.8257016,427251,067Oct 24 06:56 PM
Francisco Partners GP III LP10% OwnerOct 23Sale29.535,784170,80257,747Oct 23 07:46 PM
Francisco Partners GP, LLC10% OwnerOct 23Sale29.538,116239,6655,360Oct 23 07:49 PM
Golob David RDirectorOct 23Sale29.5313,900410,4675,360Oct 23 07:51 PM
CompanyAmbarella, Inc.
IndustrySemiconductor Equipment & Materials
Market Cap1.22BEPS (ttm)0.93
P/E44.30EPS this Y41.70%
Forward P/E23.98EPS next Y15.38%
PEG-EPS past 5Y30.90%
P/S7.04EPS next 5Y-
P/B6.65EPS Q/Q-21.60%
Dividend-Sales Q/Q-34.40%
Insider Own4.50%Inst Own44.10%
Insider Trans-43.07%Inst Trans-0.40%
Short Float22.60%EarningsSep 04/a
Analyst Recom2.20Target Price42.00
Avg Volume1.75M52W Range19.20 - 46.78
22-Oct-14 09:50AMBroadcom Beats on Q3 Earnings with Core Business Focus Zacks
22-Oct-14 08:00AMAmbarella S3 IP Camera SoC Delivers Outstanding 4K Video Quality Using State-of-the-Art H.265/HEVC Encoding Business Wire
15-Oct-14 03:29PMStocks Slump Again Heading Into Close at Investor's Business Daily
15-Oct-14 12:01PMMajor Averages Pare Losses, Then Head Lower Again at Investor's Business Daily
15-Oct-14 11:59AMGoPro stock has little upside at current price, report says at Investor's Business Daily
15-Oct-14 08:02AMGoPro, Palo Alto Lead 5 Hot Recent IPO Stocks at Investor's Business Daily
13-Oct-14 05:00PMGT Advanced to Exit Sapphire Business with Unit Closure Zacks
13-Oct-14 09:12AMAmbarella (AMBA) Upgraded From Hold to Buy at TheStreet
13-Oct-14 06:45AMChipMOS TECHNOLOGIES (IMOS) in Focus: Stock Tumbles 8.6% Zacks
10-Oct-14 01:30PMStocks Recover A Bit From Wild Morning; Zumiez Rises at Investor's Business Daily
Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition (HD) video capture, sharing, and display worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption. Its solutions enable the creation of video content for wearable sports cameras, automotive aftermarket cameras, Internet Protocol (IP) security cameras, and camcorders in the camera market; and manage IP video traffic, broadcast encoding, transcoding, and IP video delivery applications in the infrastructure market. The company sells its solutions to original design manufacturers and original equipment manufacturers through its direct sales force and logistics providers. Ambarella, Inc. was founded in 2004 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kohn LeslieCTOOct 22Option Exercise3.2010,00032,000874,474Oct 24 06:50 PM
Kohn LeslieCTOOct 22Sale42.0010,000420,000864,474Oct 24 06:50 PM
Kohn LeslieCTOOct 15Option Exercise7.5410,00075,375874,474Oct 17 05:27 PM
Kohn LeslieCTOOct 15Sale36.8110,000368,072864,474Oct 17 05:27 PM
LeGall DidierExecutive Vice PresidentOct 10Sale40.0815,000601,17957,380Oct 14 04:35 PM
TickerAZZ [NYSE]
CompanyAZZ incorporated
IndustryDiversified Machinery
Market Cap1.14BEPS (ttm)2.23
P/E19.87EPS this Y-2.10%
Forward P/E13.65EPS next Y29.26%
PEG1.54EPS past 5Y6.20%
P/S1.44EPS next 5Y12.90%
P/B2.82EPS Q/Q-17.20%
Dividend1.35%Sales Q/Q1.90%
Insider Own3.20%Inst Own84.50%
Insider Trans3.14%Inst Trans-0.28%
Short Float3.84%EarningsOct 01/b
Analyst Recom1.40Target Price52.00
Avg Volume127.33K52W Range36.71 - 49.00
03-Oct-14 08:08PM10-Q for AZZ, Inc. Company Spotlight
02-Oct-14 01:12PMAZZ INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and Exh EDGAR Online
01-Oct-14 08:27AMAZZ incorporated Announces a 7.1% Increase in Quarterly Cash Dividend from $0.14 Per Share to $0.15 Per Share PR Newswire
01-Oct-14 07:56AMAZZ incorporated Reports Financial Results for the Second Quarter of Fiscal Year 2015 PR Newswire
01-Oct-14 07:08AMAZZ INC Files SEC form 10-Q, Quarterly Report EDGAR Online
01-Oct-14 07:07AMQ2 2015 AZZ Inc Earnings Release - Before Market Open CCBN
22-Sep-14 04:05PMAZZ incorporated to Review Second Quarter of Fiscal Year 2015 Financial Results on Wednesday, October 1, 2014 PR Newswire
08-Sep-14 06:00AMAZZ INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
23-Jul-14 12:31PMAZZ INC Files SEC form 8-K/A, Change in Directors or Principal Officers EDGAR Online
09-Jul-14 06:00AMAZZ INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements EDGAR Online
AZZ incorporated manufactures electrical equipment and provides engineered services to power generation, transmission and distribution, and general industrial markets. The company operates through two segments, Electrical and Industrial Products and Services, and the Galvanizing Services. The Electrical and Industrial Products and Services segment offers specialty equipment for transmission of power from generation sources, including custom switchgear, electrical enclosures, and medium and high voltage bus ducts, as well as explosion proof and hazardous duty lighting and tubular products to multi-national companies, and small independent companies. This segment also supplies safety related equipment for the nuclear industry. It sells its products through manufacturers' representatives, distributors, agents, and internal sales force. The Galvanizing Services segment offers hot dip galvanizing services to the steel fabrication industry. This segment serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. As of February 28, 2014, the company operated 35 galvanizing plants located in Alabama, Arkansas, Arizona, Colorado, Indiana, Illinois, Louisiana, Kentucky, Minnesota, Mississippi, Missouri, Ohio, Oklahoma, Tennessee, Texas, Virginia, and West Virginia, the United States; and Ontario, Quebec, and Nova Scotia, Canada. AZZ incorporated was founded in 1956 and is headquartered in Fort Worth, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOWNEY H KIRKDirectorOct 24Sale44.113,298145,47517,442Oct 24 06:16 PM
Quinn Francis DVice PresidentOct 21Sale44.001,50066,0002,320Oct 21 06:51 PM
Pendley Timothy ESVP GALVANIZINGSep 08Buy27.501143,13531,847Sep 10 02:42 PM
Steines Robert JosephVP & Chief Accounting OfficerSep 08Buy37.332579,594257Sep 10 02:41 PM
Quinn Francis DVice PresidentMay 12Sale44.5031013,7953,820May 14 12:21 PM
TickerUAL [NYSE]
CompanyUnited Continental Holdings, Inc.
IndustryMajor Airlines
Market Cap18.54BEPS (ttm)1.70
P/E29.19EPS this Y170.20%
Forward P/E7.55EPS next Y29.00%
PEG0.80EPS past 5Y15.30%
P/S0.48EPS next 5Y36.45%
P/B5.53EPS Q/Q64.80%
Dividend-Sales Q/Q3.30%
Insider Own0.20%Inst Own96.50%
Insider Trans0.40%Inst Trans0.09%
Short Float2.70%EarningsOct 23/b
Analyst Recom2.10Target Price57.44
Avg Volume6.43M52W Range29.63 - 52.45
24-Oct-14 06:35PMFinal Glance: Airlines companies AP
24-Oct-14 02:05PMNever Mind Ebola, Airline Stocks Keep Flying at Barrons.com
24-Oct-14 01:27PMMedical, Airline Stocks Move As Ebola Arrives In NYC at Investor's Business Daily
24-Oct-14 01:17PMMidday Glance: Airlines companies AP
24-Oct-14 01:13PMAirlines shake off travel fears; gains on earnings at CNBC
24-Oct-14 11:08AMStocks Not Shocked By NYC Ebola Case at Forbes
24-Oct-14 10:40AMEarly Glance: Airlines companies AP
24-Oct-14 10:34AM10:34 am United Continental: United Airlines will launch four new Pacific routes next week, beginning with nonstop service between Los Angeles and Melbourne, Australia, and between San Francisco and Tokyo's Haneda Airport and also two new r Briefing.com
24-Oct-14 10:30AMUnited Expands Pacific Footprint with Four New Route Launches Next Week PR Newswire
24-Oct-14 08:40AMUnited Continental Beats Q3 Earnings, Misses Revenues Zacks
United Continental Holdings, Inc., through its subsidiaries, provides passenger and cargo transportation services. The company transports people and cargo through its mainline operations, which use jet aircraft with 118 seats, and its regional operations. It operates in the United States, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company also sells fuel, as well as offers catering, ground handling, and maintenance services for third parties. As of May 12, 2014, it operated through a fleet of approximately 700 mainline aircraft. The company was formerly known as UAL Corporation and changed its name to United Continental Holdings, Inc. in October 2010. United Continental Holdings, Inc. was founded in 1934 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foland Jeffrey T.EVP- Mktg, Tech and StrgyOct 23Option Exercise45.696,000274,14058,856Oct 24 06:10 PM
Foland Jeffrey T.EVP- Mktg, Tech and StrgyOct 23Sale50.006,000300,00052,856Oct 24 06:10 PM
Hart Gregory LEVP & COOOct 14Sale41.611,03943,23320,880Oct 15 05:01 PM
Hart Gregory LEVP & COOJul 14Sale45.731,04047,55921,919Jul 16 04:33 PM
SMISEK JEFFERY AChairman, President & CEOApr 28Buy39.6220,000792,380487,838Apr 28 11:54 AM
CompanyNxstage Medical, Inc.
IndustryMedical Appliances & Equipment
Market Cap914.47MEPS (ttm)-0.37
P/E-EPS this Y-19.20%
Forward P/E-EPS next Y24.40%
PEG-EPS past 5Y24.10%
P/S3.24EPS next 5Y20.00%
P/B4.79EPS Q/Q-100.00%
Dividend-Sales Q/Q13.10%
Insider Own1.70%Inst Own95.30%
Insider Trans17.96%Inst Trans-0.01%
Short Float6.38%EarningsNov 06/b
Analyst Recom1.90Target Price17.50
Avg Volume279.67K52W Range8.77 - 15.65
24-Oct-14 08:00AMNxStage Director of Public Policy Honored for Dedication to Patient Advocacy PR Newswire
08-Oct-14 01:04PMNXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
08-Oct-14 09:57AMNxStage Kidney Care Hosts Grand Opening Event at Florida Dialysis Center PR Newswire
07-Oct-14 08:00AMNxStage® to Report Third Quarter 2014 Financial Results PR Newswire
01-Oct-14 05:01PMNXSTAGE MEDICAL, INC. Files SEC form 10-Q/A, Quarterly Report EDGAR Online
16-Sep-14 08:00AMNxStage Announces FDA Clearance of Single Needle Technology PR Newswire
10-Sep-14 08:00AMNxStage Patients Participate in 257-Mile Tour DaVita Bike Ride PR Newswire
20-Aug-14 10:00AMNxStage Kidney Care Opens New Orlando Florida Dialysis Center PR Newswire
12-Aug-14 08:00AMAllan J. Collins, M.D., to join NxStage as Senior Medical Advisor PR Newswire
07-Aug-14 08:07AMNXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product is the NxStage System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in two segments, System One and In-Center. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment. This segment also sells extracorporeal disposable products, which are primarily used for in-center dialysis treatments for patients with end-stage renal disease (ESRD) in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. NxStage Medical, Inc. markets its products through direct sales force and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Robert S.President, Kidney CareOct 23Option Exercise4.5443,470197,35491,098Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 23Sale14.5343,470631,61947,628Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Option Exercise4.541,9008,62649,528Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Sale14.501,90027,55047,628Oct 24 06:10 PM
Burbank Jeffrey HCEOOct 20Sale14.007,584106,176821,481Oct 22 04:26 PM
1 2 3 4 5 6 7 8 9 10 next